RIMONDI, ALESSANDRO

RIMONDI, ALESSANDRO  

Universita' degli Studi di MILANO  

Mostra records
Risultati 1 - 11 di 11 (tempo di esecuzione: 0.0 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
Acquired Refractory Iron Deficiency Anemia 2021 Rimondi A.Motta I. + Article (author) -
An unprecedented challenge: The north italian gastroenterologist response to COVID-19 2022 Tontini G. E.Aldinio G.Nandi N.Rimondi A.Iavarone M.Lampertico P.Vecchi M. + Article (author) -
Artificial intelligence in gastrointestinal endoscopy for inflammatory bowel disease: a systematic review and new horizons 2021 Tontini G. E.Rimondi A.Vecchi M.Bezzio C. + Article (author) -
Clinical features of type 1 and 2 refractory celiac disease: Results from a large cohort over a decade 2022 Elli, LucaSoru, PietroRoncoroni, LedaRossi, Francesca GaiaFerla, ValeriaBaldini, LucaNandi, NicolettaScaramella, LuciaRimondi, AlessandroFusco, NicolaCroci, Giorgio AlbertoGianelli, UmbertoBarbieri, MarziaCostantino, AndreaVaira, ValentinaFerrero, StefanoTontini, Gian EugenioDoneda, LuigiaVecchi, Maurizio + Article (author) -
Endoscopy during the Covid-19 outbreak : experience and recommendations from a single center in a high-incidence scenario 2020 Elli L.Rimondi A.Scaramella L.Vecchi M.Mangioni D.Gori A.Penagini R. + Article (author) -
Endoscopy during the COVID-19 pandemic: Is it time to down-grade personal protective equipment for vaccinated personnel? 2021 Rimondi A.Tontini E.Gori A.Vecchi M.Penagini R. + Article (author) -
Fogging IBD Management: An Unusual Case of IBD Flare-up During the COVID-19 Outbreak 2020 Rimondi, AlessandroTontini, Gian EugenioMazza, StefanoCaprioli, FlavioLampertico, PietroVecchi, Maurizio + Article (author) -
High rates of 30-day mortality in patients with cirrhosis and COVID-19 2020 Triolo M.Massironi S.Aghemo A.Pedaci M.Rimondi A.Rumi M. G.Bonfanti P.Lampertico P. + Article (author) -
Jejunal necrosis following caustic (NH3) Ingestion in patient with total gastrectomy 2021 Nandi N.Rimondi A.Tontini G. E.Vecchi M. Article (author) -
Safety and clinical efficacy of the double switch from originator infliximab to biosimilars CT-P13 and SB2 in patients with inflammatory bowel diseases (SCESICS): A multicenter cohort study 2021 Mazza S.Rimondi A.Marinoni B.Munari F.Pastorelli L.Cavallaro F.Ferraris L.Colucci A.Eugenio Tontini G.Vecchi M.Caprioli F. + Article (author) -
Safety and effectiveness of up to 3 years' bulevirtide monotherapy in patients with HDV-related cirrhosis 2022 Loglio AUceda Renteria SCPerbellini RRimondi AFarina ETrombetta EManunta MLampertico P. + Article (author) -